Systematic review of 9 studies (29 patients) with both FSHD and myasthenia gravis: MG began a pooled mean 24.21 years after FSHD onset, at mean age 62.62; all tested were AChR antibody positive and 89.7% improved with standard MG therapy.
Meta-analysisn = 29
Gunawan et al. Co-Occurrence of Facioscapulohumeral Muscular Dystrophy and Myasthenia Gravis: A Systematic Review and Meta-Analysis of Individual Patient Data